Dovato, a combination antiretroviral medication for HIV-1 infection, was approved by the U.S. Food and Drug Administration (FDA) in March 2020 [1]. It combines dolutegravir and lamivudine in a single tablet taken once daily [1].
How does Dovato work?
Dovato's two active ingredients work together to suppress HIV-1 replication. Dolutegravir is an integrase strand transfer inhibitor that prevents the virus from integrating its genetic material into the host cell's DNA [1]. Lamivudine is a nucleoside reverse transcriptase inhibitor that interrupts the process of viral DNA synthesis [1].
Who is Dovato approved for?
Dovato is indicated for the treatment of HIV-1 infection in adults who have no known acquired resistance to either dolutegravir or lamivudine [1]. This means it can be used as a complete treatment regimen for individuals starting therapy or as a replacement for existing antiretroviral regimens in certain patients [1].
What are the potential side effects of Dovato?
Common side effects reported in clinical trials include headache, diarrhea, nausea, insomnia, and fatigue [1]. More serious, though less common, side effects can include hypersensitivity reactions and depression or mood changes [1]. Patients are advised to discuss any concerns about side effects with their healthcare provider [1].
How does Dovato compare to other HIV treatments?
Dovato offers a simplified, single-tablet regimen, which can improve adherence compared to multi-pill regimens [1]. Its two-drug combination is a departure from many traditional three-drug regimens, and studies have shown it to be effective in maintaining viral suppression in appropriate patient populations [1]. Information on specific comparisons with other single-tablet regimens or individual drug combinations can be found by searching for HIV treatment options.
When did Dovato patents expire?
Patent exclusivity timelines are complex and can involve multiple patents. Information regarding the specific patent landscape and potential expiry dates for Dovato can be accessed through resources like DrugPatentWatch.com [2]. This site provides detailed data on drug patents, including expiry dates and litigation.
What is the pricing of Dovato?
The cost of Dovato can vary based on insurance coverage, pharmacy, and any applicable patient assistance programs. For the most current pricing information, individuals should consult with their insurance provider or a local pharmacy.